Trials / Recruiting
RecruitingNCT06473610
Residual Embolism Evaluated With Single Photon Emission Computed Tomography
Residual Embolism Evaluated With Single Photon Emission Computed Tomography - The RESPECT Cohort
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 358 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Saint Etienne · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
Major progress achieved in diagnostic and therapeutic strategies has substantially improved the short-term prognosis of patients with pulmonary embolism (PE). These improvements have led to a shift from an acute to a chronic condition of venous thromboembolism, justifying the recent development of Chronic Thrombo-embolic Disease (CTED). In most of the situations, it is due to a residual pulmonary vascular obstruction (RPVO) which can be assessed by pulmonary scintigraphy.
Detailed description
Planar ventilation/perfusion (V/Q) scintigraphy is the gold standard, but for several months, V/Q single photon emission computed tomography (SPECT) is recommended in the guidelines. The aim of this study is to evaluate the performances of various SPECT protocols to quantified RPVO and compared to planar scintigraphy to evaluate the RPVO.
Conditions
Timeline
- Start date
- 2024-06-27
- Primary completion
- 2026-04-01
- Completion
- 2026-04-01
- First posted
- 2024-06-25
- Last updated
- 2025-08-07
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT06473610. Inclusion in this directory is not an endorsement.